In this bi-weekly series, Dr Sue Clenton explores the growing interest and potential of cannabinoid-based therapies to address unmet needs in women’s health conditions.
Since launching its legal support helpline, Releaf Cannabis Clinic has received increasing reports from patients experiencing stigma and discrimination.
Introducing The Medical Cannabis Employer Handbook
Medical cannabis has been legal in the UK since 2018, but for many patients, taking or carrying their prescribed medication in public still comes with uncertainty. Since launching its legal […]
Dr Sue Clenton, Medical Director at Releaf Cannabis Clinic, shares her insight from the frontline of an emerging field of medicine.
By Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf […]
Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine.
In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field […]
In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field […]
Dr Sue Clenton, Medical Director of Releaf cannabis clinic explains what it takes to go from a few hundred to thousands of patients, without compromising on the quality of care. […]
The conversation around workers’ rights and medical cannabis is still at a very early stage in the UK.
Dr Sue Clenton, Medical Director at Releaf explores the role that clinics can play in recruiting and training the next generation of medical cannabis professionals.
In a special edition of the Business of Cannabis Podcast, we go from anecdote to evidence with Dr Anne Katrin Schlag, Head of Research at Drug Science, and Graham Woodward, Chief Operating Officer at Releaf.
By Dr Sue Clenton, Medical Director, Rupa Shah, Chief Legal and Compliance Officer, and Graham Woodward, Chief Operations Officer, Releaf In a healthcare landscape as tightly regulated as the UK’s […]
As the UK’s fastest-growing medical cannabis clinic, Releaf is committed to not only addressing an unmet healthcare need but doing so in a safe and clinically responsible manner.
UK medical cannabis clinic, Releaf, is investing in an ambitious new research programme to collect critical real-world evidence on the effects of medical cannabis treatments. Could it help bridge the […]
Written by Releaf To establish whether medical cannabis is the right option for you, you need to know whether it’s within your budget. Here, Releaf breaks down how much it […]
Written by Releaf Releaf offers every patient at the clinic a medical cannabis card to help ensure ease and peace of mind when going about daily life with your prescription. […]
Releaf examines what to consider when exploring this treatment option for yourself or a loved one.
Lyphe is proud to announce the launch of its new low-cost medical cannabis line, Noidecs Vital, designed to address affordability issues for medical patients. Recognising the financial barriers many patients […]
Greek Health Minister to speak at Cannabis Europa London on Greece’s groundbreaking new medical cannabis programme, joined by Curaleaf executive chairman, Boris Jordan, and former Wimbledon champion, Pat Cash. Cannabis […]
Curaleaf International, a market-leading global cannabis company, has been announced as the Headline Partner for Cannabis Europa, scheduled to take place in London on 25-26 June, 2024. Cannabis Europa is […]
From 26th February, the medical cannabis division of Rokshaw Ltd is rebranding to Curaleaf Laboratories. Since its inception in 2012 by founders Jonathan and Richard Hodgson, Rokshaw has created an […]
Rokshaw can today announce the exclusive UK manufacture and distribution of medical cannabis products under the Four20 Pharma brand. In line with market growth and patient demand, Rokshaw has bolstered its […]
